Knowledge Content
Bodybuilding PCT (post-cycle recovery) is its most common scenario. The core objective is to activate endogenous testosterone secretion suppressed by steroids. The primary route of administration is **subcutaneous injection** (oral bioavailability <10%, nasal spray efficiency is only 30% of injection). The recommended dose is 100-200 μg daily, divided into two injections (8 AM and 8 PM)-this timing coincides with the physiological pulsatile secretion rhythm of GnRH in the human body, avoiding receptor desensitization. The cycle is designed for 4-6 weeks: high-intensity activation with 200μg daily for the first 2 weeks, then reduced to 100μg daily for maintenance for the next 2-4 weeks. Combining this with tamoxifen (20mg daily) can shorten testosterone recovery time by 40%. It is important to rotate injection sites (abdomen, lateral thigh) to avoid subcutaneous induration caused by prolonged use in the same site.https://www.fiercerawsource.com/peptides/premium-high-purity-peptides-gonadorelin-2mg.html
In clinical diagnostic settings, its use focuses on "pituitary function assessment." For patients with hypogonadotropic hypogonadism, a **100μg intravenous bolus injection** is used. The peak levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are measured 15-30 minutes after injection: a 3-5 fold increase from baseline indicates normal pituitary function, with the cause in the hypothalamus; no significant increase indicates pituitary-related damage. This method is more accurate than traditional hormone stimulation tests and is less burdensome on the body.
In assisted reproductive technology settings, it needs to be used in conjunction with gonadotropins. In female ovulation induction protocols, 50-100 μg is injected subcutaneously daily for 7-10 days to pre-treat the ovaries, increasing follicle sensitivity to follicle-stimulating hormone (FSH) by 25%. In male oligospermia treatment, a pulsed infusion pump (releasing 10 μg every 90 minutes) simulates a physiological pulse pattern, avoiding receptor downregulation caused by continuous high concentrations. This can increase sperm density by 60%-80% within 3 months.
Key precautions: 1. Avoid prolonged high-dose use; exceeding 6 weeks may cause pituitary GnRH receptor desensitization, inhibiting hormone secretion. 2. Monitor hormone levels; testosterone should be tested weekly during PCT to ensure it remains within the "recovery window" of 300-500 ng/dL. 3. Side effects management: approximately 5%-8% of users experience transient hot flashes and nausea, which usually subside within 3 days of medication. In severe cases, the dose may be halved.
Overall, the essence of using Gonadorelin lies in "scenario matching + rhythm regulation". The method of administration and dosage should be selected according to specific needs, and a balance between efficacy and safety should be achieved through professional monitoring.
